Donaldson Capital Management’s GSK GSK Stock Holding History

Donaldson Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,504	Closed	-$217K	–	158
2016 Q4	$217K	Sell	4,504 -454	-9%	-$22.4K	0.03%	144
2016 Q3	$267K	Buy	+4,958	New	+$272K	0.04%	126
2014 Q4	–	Sell	-5,942	Closed	-$341K	–	153
2014 Q3	$341K	Buy	5,942 +946	+19%	+$58K	0.05%	101
2014 Q2	$334K	Sell	4,996 -40	-0.8%	-$2.71K	0.05%	101
2014 Q1	$336K	Hold	5,036	–	–	0.06%	87
2013 Q4	$336K	Buy	5,036 +320	+7%	+$20.7K	0.06%	81
2013 Q3	$296K	Hold	4,716	–	–	0.06%	81
2013 Q2	$295K	Buy	+4,716	New	+$299K	0.07%	74

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Donaldson Capital Management's GSK Position: Q1 2017 in Review

Donaldson Capital Management sold out of GSK (GSK) in Q1 2017, closing a stake of 4,504 shares — an estimated $217K sold.

Donaldson Capital Management first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $341K in Q3 2014. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

Donaldson Capital Management reported no remaining GSK position as of Q1 2017 after selling out during the quarter.
Donaldson Capital Management sold 4,504 GSK shares in Q1 2017, an estimated $217K.
Donaldson Capital Management first reported a position in GSK in Q2 2013 and held it in 8 quarters.
Donaldson Capital Management's GSK position peaked at $341K in Q3 2014.
786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Donaldson Capital Management's 13F filing for Q1 2017, filed 10 May 2017.